SYRESPYRE THERAPEUTICS INC
CUSIP 00773J202 · common stock
2 tracked investors held SPYRE THERAPEUTICS INC (SYRE) at the end of Q3 2026, worth $313.3M in total. The largest holder was Perceptive Advisors, with 5.1% of its portfolio. Chuck Royce sold out of its position this quarter.
Holders · Q3 2026
2
New holders
0
Value held
$313.3M
Quarter-end price (est.)
$89.03
Investors holding SYRE · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Perceptive Advisors Perceptive Advisors LLC | 5.09% | 3,280,943 | $292.1M | REDUCE-24.0% |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.90% | 237,567 | $21.2M | REDUCE-16.3% |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Chuck Royce | 0.04% | 51,789 | $4.6M | EXIT |